NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
NCT06303180 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-11-14
Summary
Background:
Many disorders of the head and neck can affect a person s hearing; balance; smell; taste; swallowing; voice; or speech. These disorders include cancers and genetic and inflammatory diseases. To find better ways to diagnose and treat these disorders, researchers need to study tissues and other biological samples from people who have them.
Objective:
To collect biological samples for a repository that will be used for research.
Eligibility:
People of any age with a disorder of the head and neck that requires the taking of biological samples. The conditions may be any that affect hearing; balance; smell; taste; swallowing; voice; or speech.
Design:
Part 1: Participants will give permission for their leftover tissue samples to be used for research. These are tissue samples from the head and neck that were collected in the course of routine tests and care or other research studies. Information on each participant s age, diagnosis, and previous treatments will also be collected.
Part 2: Some participants may be asked for more samples. All those aged 3 years or older will have a physical exam. They will provide blood and saliva samples. A cotton swab or brush will be used to collect cells from the inside of the cheek.
Participants 18 years or older may have additional tests. They may provide nasal secretions: A piece of gelfoam or a sponge will be placed in the nose to soak up secretions for 5 to 10 minutes. They may have biopsies: Small samples of tissue will be cut from the skin and the tissue lining the mouth.
Samples may be used for genetic testing.
Conditions
- Hearing Loss
- Head and Neck Neoplasms
- Hearing Disorders
- Laryngeal Disease
Sponsors & Collaborators
-
National Institute on Deafness and Other Communication Disorders (NIDCD)
lead NIH
Principal Investigators
-
Joshua M Levy, M.D. · National Institute on Deafness and Other Communication Disorders (NIDCD)
Eligibility
- Min Age
- 3 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-04
- Primary Completion
- 2033-12-30
- Completion
- 2033-12-30
Countries
- United States
Study Locations
More Related Trials
-
An Investigator Initiated Study for OTOV101N+OTOV101C Injection
NCT05901480 ·Status: UNKNOWN ·Phase: NA
-
Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development of Novel Phenotyping Measures, and Discovery of Therapeutic Targets
NCT04806282 ·Status: RECRUITING
-
The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults
NCT02941627 ·Status: COMPLETED ·Phase: NA
-
Single-sided Deafness and Cochlear Implantation
NCT05052944 ·Status: COMPLETED
-
Cochlear Implantation in Cases of Single-Sided Deafness
NCT02203305 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population
NCT06293482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss
NCT04766853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
NCT05776459 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cochlear Implants for Adults With Single-sided Deafness
NCT02259192 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic of Various Ototoxicity Induced by Cancer Treatment
NCT06490029 ·Status: RECRUITING
-
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
NCT01621256 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autoimmunity in Inner Ear Disease
NCT00000361 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
NCT00023036 ·Status: COMPLETED
-
Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss
NCT02997189 ·Status: TERMINATED ·Phase: PHASE2
-
Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
NCT02811549 ·Status: COMPLETED ·Phase: NA
-
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
NCT00694421 ·Status: COMPLETED
-
Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT02105441 ·Status: COMPLETED
-
A Study of the Clinicopathologic Behaviour of the Different Types of Unsafe Chronic Otitis Media
NCT00270660 ·Status: UNKNOWN
-
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
NCT06249919 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Coherent Optical Detection of Middle Ear Disease
NCT05353569 ·Status: RECRUITING ·Phase: NA
-
Vaccination for Middle Ear Infection
NCT00001605 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Donepezil on Speech Recognition in Cochlear Implant Users
NCT05438264 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor
NCT03292458 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
FX-322 in Adults With Acquired Sensorineural Hearing Loss
NCT05086276 ·Status: COMPLETED ·Phase: PHASE2
-
CNS Infections Effect on the Inner Ear
NCT03715569 ·Status: UNKNOWN